Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bespoke Treatment is a mental health clinical group specializing in interventional psychiatry for treatment-resistant conditions. The company provides advanced therapeutic options including Transcranial Magnetic Stimulation (TMS), intravenous ketamine infusions, and Spravato (esketamine) nasal spray. Their clinical model combines these biological treatments with intensive outpatient programs and psychotherapy to provide a comprehensive approach to mental wellness. Operating multiple locations across the United States, Bespoke Treatment focuses on personalized care for patients who have not responded to traditional antidepressant medications. The organization emphasizes evidence-based protocols and data-driven outcomes to improve patient quality of life.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bespoke Treatment.